Library Hosts Discussion on Organ Sale Ethics
Experts addressed the history and legal barriers surrounding organ commerce at a Midtown Manhattan event.
Updated on Oct. 20, 2026 in Healthcare
Live Poll
Should the government allow the buying and selling of human organs for medical transplants?
The Stavros Niarchos Foundation Library in Midtown Manhattan hosted a public discussion regarding the ethics of organ sales. Led by experts from the Johns Hopkins Berman Institute of Bioethics, the event explored the complex intersection of medical advancements and legal regulations.
Why it matters
The panel provided a platform for community dialogue on the ethical dilemmas inherent in organ transplantation. It aimed to inform the public about the evolution of transplant standards and the ongoing debate over the commercialization of human organs.
In 1983, a kidney brokerage business charged up to $10,000 for a single organ. Brokers typically retained between $2,000 and $3,000 of that price as a fee per transaction.
The players
Jeffrey Kahn
He is a faculty member at the Johns Hopkins Berman Institute of Bioethics who moderated the discussion.
Mario Macis
He is an expert from the Johns Hopkins Berman Institute of Bioethics who co-led the panel session.
Harvey Barry Jacobs
He operated a kidney brokerage business in 1983 that charged individuals for organ access before the current federal ban.
The details
The event featured a presentation by faculty from the Johns Hopkins Berman Institute of Bioethics, followed by a moderated discussion and audience questions. Speakers analyzed how medical breakthroughs like the introduction of cyclosporine in the early 1980s transformed transplant viability and necessitated new regulatory frameworks.
Timeline
In 1983, Harvey Barry Jacobs operated an illegal kidney brokerage business.
Congress passed the National Organ Transplant Act in 1984 to prohibit organ sales.
The Stavros Niarchos Foundation Library hosted the ethics discussion on October 19, 2026.
Market Landscape
The discussion highlighted the regulatory shifts following the National Organ Transplant Act, which fundamentally reshaped the medical landscape. This event underscores how legislative action remains the primary tool for countering commercial interests in the healthcare sector.
Residents attending such forums gain critical insights into how medical laws directly influence patient rights and access to care. The session underscores the importance of informed public discourse when considering the evolution of organ transplant policies.
The takeaway
The history of transplant brokerage services serves as a reminder of the ethical safeguards established by modern legislation. Citizens should remain informed about these policies to understand the boundary between medical innovation and commerce.
Further reading
For additional context on medical regulations and policy, explore the Healthcare section.
Source note: This article includes information reported by The National Herald.
Live Poll
Should the government allow the buying and selling of human organs for medical transplants?
